Assyro AI

Orange Book product · Brand (NDA)

ORENITRAM

TREPROSTINIL DIOLAMINE

Brand (NDA)NDA 203496RX UNITED THERAP

At a glance

Dec 20, 2013

Approved

Brand (NDA)

Application

Not listed

TE code

9

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 20, 2013

    12 yr 8 mo ago

  2. Patent 9393203 expires

    Listed drug product patent expiration.

    Apr 27, 2026

    2 mo ago

  3. Today

  4. Patent 7417070 expires

    Listed drug substance patent expiration.

    Jul 30, 2026

    in 1 mo

  5. Exclusivity ends · ODE-272

    Orphan-drug exclusivity (7 years)

    Oct 18, 2026

    in 4 mo

  6. Patent 11723887 expires

    Listed drug substance patent expiration.

    Dec 15, 2028

    in 2 yr 6 mo

  7. Patent 9593066 expires

    Listed drug substance patent expiration.

    Dec 15, 2028

    in 2 yr 6 mo

  8. Patent 9604901 expires

    Listed drug substance patent expiration.

    Dec 15, 2028

    in 2 yr 6 mo

  9. Patent 8410169 expires

    Listed drug product patent expiration.

    Feb 13, 2030

    in 3 yr 9 mo

  10. Patent 8349892 expires

    Listed drug product patent expiration.

    Jan 22, 2031

    in 4 yr 8 mo

  11. Patent 8747897 expires

    Listed drug product patent expiration.

    Aug 11, 2031

    in 5 yr 3 mo

  12. Patent 8747897 expires

    Listed drug product patent expiration.

    Aug 11, 2031

    in 5 yr 3 mo

Pharmaceutical detail

Active ingredient

TREPROSTINIL DIOLAMINE

Strength

EQ 0.125MG BASE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 203496

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (1)

  • ODE-272Orphan-drug exclusivity (7 years)

    Oct 18, 2026

    in 4 mo

Listed patents (9)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9393203Apr 27, 20262 mo ago
ProductU-1877
7417070Jul 30, 2026in 1 mo
Substance
11723887Dec 15, 2028in 2 yr 6 mo
Substance
9593066Dec 15, 2028in 2 yr 6 mo
Substance
9604901Dec 15, 2028in 2 yr 6 mo
SubstanceDelisted
8410169Feb 13, 2030in 3 yr 9 mo
Product
8349892Jan 22, 2031in 4 yr 8 mo
Product
8747897Aug 11, 2031in 5 yr 3 mo
ProductU-2725
8747897Aug 11, 2031in 5 yr 3 mo
ProductU-2724
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.